The comprehensive programme for the BOIF will feature over 7 hours of high-level keynotes, panel discussions, and corporate presentations covering all aspects of the bio-pharma obesity science and market, including drug development and technology, as well as highlighting investment opportunities. The sessions will be made available on demand for the virtual audience the week after the JP Morgan meeting. This forum will also set the stage for our first Obesity focused European event scheduled for the 17th - 19th of June 2025 in Leipzig. Key topics to be covered at the upcoming event include:
Saturday, 11th of January:
- Fireside Chat with Dr. Bei B. Zhang, Corporate VP & TA Head - Diabetes, Obesity & MASH, Novo Nordisk A/S
- Potential Magnitude of Market & Impact on the Healthcare System Panel
- BioPharma Dealmaking: Building the Pipeline Panel
- Personalized Approaches to Treating Obesity Panel
- Unmet Needs & NextGen Therapeutics Panel
- Obesity, Cardiovascular & Metabolic Diseases Platforms Panel
- Innovation in Digital, Tech & Dx for Obesity, Diabetes & MASH Panel
- Investor Roundtable
More information here!